Skip to content
Clinical Trials – home

Klinikum Nuernberg

Verifiedinfo

Germany Prof.-Ernst-Nathan-Strasse 1, St. Johannis, 90419 Nürnberg, Germany

  • 49 trials recruiting
  • Plasma cell myeloma · Oesophageal adenocarcinoma · Acute myeloid leukaemia
  • Adults and children

About Specializations

Klinikum Nuernberg in Nürnberg, Germany specialises in clinical trials of conditions such as Plasma cell myeloma, Oesophageal adenocarcinoma, Acute myeloid leukaemia, Non-small cell lung cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Hematologic Malignancies

The medical center is at the forefront of research in hematologic malignancies, focusing on innovative therapies for conditions such as acute myeloid leukemia and mantle cell lymphoma. The center's work in this area aims to improve treatment outcomes through advanced therapeutic regimens and stem cell transplantation techniques.

  • Acute Myeloid Leukemia (AML)
  • Mantle Cell Lymphoma
  • Multiple Myeloma

By integrating cutting-edge research with clinical practice, the center is enhancing the efficacy of existing treatments and exploring new therapeutic avenues.

Oncology

Specializing in oncology, the center conducts pivotal studies on various cancers, including non-small cell lung cancer and gastrointestinal tumors. The research focuses on novel drug combinations and personalized medicine approaches to improve patient survival and quality of life.

  • Non-Small Cell Lung Cancer (NSCLC)
  • Gastrointestinal Tumors
  • Melanoma

The center's commitment to oncology research is evident in its efforts to develop targeted therapies and immunotherapies that address the unique genetic and molecular profiles of tumors.

Cardiology

In the field of cardiology, the center is pioneering research on acute coronary syndromes and atrial fibrillation. The focus is on optimizing antiplatelet and anticoagulation therapies to reduce cardiovascular events while minimizing bleeding risks.

  • Acute Coronary Syndromes
  • Atrial Fibrillation

Through its research, the center is advancing the understanding of cardiovascular diseases and improving therapeutic strategies for better patient outcomes.

Respiratory Diseases

The center is a leader in research on respiratory diseases, particularly focusing on chronic obstructive pulmonary disease and chronic lung disease in premature infants. The research aims to develop new treatments that reduce disease burden and improve respiratory function.

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Chronic Lung Disease in Premature Infants

By exploring innovative therapeutic approaches, the center is contributing to the advancement of respiratory care and enhancing the quality of life for patients with chronic respiratory conditions.

Autoimmune and Inflammatory Diseases

Research at the center includes a strong focus on autoimmune and inflammatory diseases, such as psoriatic arthritis and systemic sclerosis. The center is investigating the potential of immunosuppressive therapies and biologics to manage disease activity and improve patient outcomes.

  • Psoriatic Arthritis
  • Systemic Sclerosis

Through its research, the center is enhancing the understanding of these complex diseases and developing strategies to improve patient care and quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Prof.-Ernst-Nathan-Strasse 1, St. Johannis90419 NürnbergGermany
Recruiting now
49 trials
Conditions studied
89
Partner status
Verified

More sites in NürnbergGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

106 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BioNTech SE
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:BioNTech SE
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Daiichi Sankyo Inc.
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Institut fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cevostamab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Incyte Corp.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Arsenic Trioxide
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:AZD0120
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BLEXIMENIB
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.